Fifth Third Bancorp acquired a new position in the Invesco Biotechnology & Genome ETF on August 17, 2026.
1 report, 1 independent
Updated Aug 17
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Fifth Third Bancorp acquired a new position in the Invesco Biotechnology & Genome ETF on August 17, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Fifth Third Bancorp
American bank holding company
Related events
- Fifth Third Bancorp purchased a new position in the Vanguard U.S. Quality Factor ETF on August 25, 2026.
- Fifth Third Bancorp bought a new position in the iShares Copper and Metals Mining ETF on August 16, 2026.
- Fifth Third Bancorp increased its stake in the iShares Global Utilities ETF on August 29, 2026.
- Fifth Third Bancorp purchased a new stake in the Fidelity Preferred Securities & Income ETF.
- Fifth Third Bancorp bought a new stake in the GraniteShares Bloomberg Commodity Broad Strategy No K-1 ETF.